SLDB CEO Cumbo Alexander sells 80,258 shares at $6.44 while company posts -40.6% annual revenue decline and $-45.8M net loss
CEO Cumbo Alexander sold 80,258 shares (80.3K shares) for $516,612.72 ($516.6K) at $6.44, reducing his holdings by 22.9% from 351,189 to 270,931 shares. This sale occurs as Solid Biosciences reports severe financial deterioration: latest quarterly revenue of $0.00, annual net income of $-45,776,000.00 ($-45.8M), and 40.6% year-over-year revenue decline. While the stock has appreciated 46.0% over the past 90 days and 18.0% over 30 days (and trades near its 52-week high of $7.07), the company remains deeply unprofitable and has contracted substantially in revenue, raising questions about the sustainability of recent gains and the strategic rationale for this significant reduction in CEO equity exposure.